These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27029796)

  • 1. Sorafenib Decreases Tumor Exposure to an Anti-carcinoembryonic Antigen Monoclonal Antibody in a Mouse Model of Colorectal Cancer.
    Thomas VA; Balthasar JP
    AAPS J; 2016 Jul; 18(4):923-32. PubMed ID: 27029796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic mAb-mAb interaction: anti-VEGF mAb decreases the distribution of anti-CEA mAb into colorectal tumor xenografts.
    Abuqayyas L; Balthasar JP
    AAPS J; 2012 Sep; 14(3):445-55. PubMed ID: 22528507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Catch-and-Release" Anti-Carcinoembryonic Antigen Monoclonal Antibody Leads to Greater Plasma and Tumor Exposure in a Mouse Model of Colorectal Cancer.
    Engler FA; Polli JR; Li T; An B; Otteneder M; Qu J; Balthasar JP
    J Pharmacol Exp Ther; 2018 Jul; 366(1):205-219. PubMed ID: 29735609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target mediated disposition of T84.66, a monoclonal anti-CEA antibody: application in the detection of colorectal cancer xenografts.
    Urva SR; Balthasar JP
    MAbs; 2010; 2(1):67-72. PubMed ID: 20081377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody.
    Cai W; Olafsen T; Zhang X; Cao Q; Gambhir SS; Williams LE; Wu AM; Chen X
    J Nucl Med; 2007 Feb; 48(2):304-10. PubMed ID: 17268029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologically Based Modeling of the Pharmacokinetics of "Catch-and-Release" Anti-Carcinoembryonic Antigen Monoclonal Antibodies in Colorectal Cancer Xenograft Mouse Models.
    Polli JR; Engler FA; Balthasar JP
    J Pharm Sci; 2019 Jan; 108(1):674-691. PubMed ID: 30321546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
    Blumenthal RD; Sharkey RM; Haywood L; Natale AM; Wong GY; Siegel JA; Kennel SJ; Goldenberg DM
    Cancer Res; 1992 Nov; 52(21):6036-44. PubMed ID: 1394228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologically based pharmacokinetic model for T84.66: a monoclonal anti-CEA antibody.
    Urva SR; Yang VC; Balthasar JP
    J Pharm Sci; 2010 Mar; 99(3):1582-600. PubMed ID: 19774657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy.
    Stein R; Goldenberg DM
    Mol Cancer Ther; 2004 Dec; 3(12):1559-64. PubMed ID: 15634649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts.
    Jakowatz JG; Beatty BG; Vlahos WG; Porudominsky D; Philben VJ; Williams LE; Paxton RJ; Shively JE; Beatty JD
    Cancer Res; 1985 Nov; 45(11 Pt 2):5700-6. PubMed ID: 4053043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
    Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
    Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens.
    Sharkey RM; Gold DV; Aninipot R; Vagg R; Ballance C; Newman ES; Ostella F; Hansen HJ; Goldenberg DM
    Cancer Res; 1990 Feb; 50(3 Suppl):828s-834s. PubMed ID: 2297729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.
    Sundaresan G; Yazaki PJ; Shively JE; Finn RD; Larson SM; Raubitschek AA; Williams LE; Chatziioannou AF; Gambhir SS; Wu AM
    J Nucl Med; 2003 Dec; 44(12):1962-9. PubMed ID: 14660722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of combination of low dosage 131I-labeled anti-carcinoembryonic antigen antibody C50 and 5-fluorouracil on tumor growth of colorectal cancer xenografts in nude mice].
    Zheng CX; Zhan WH; Cai SR; He YL; Lin ZJ
    Ai Zheng; 2003 Apr; 22(4):354-7. PubMed ID: 12703987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applicability of carcinoembryonic antigen-specific monoclonal antibodies to radioimmunoguided surgery for human colorectal carcinoma.
    Kim JC; Kim WS; Ryu JS; Oh SJ; Lee DH; Koo KH; Roh SA; Kim HC; Yu CS; Kang GH; Bodmer WF
    Cancer Res; 2000 Sep; 60(17):4825-9. PubMed ID: 10987293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of PBPK modeling to predict monoclonal antibody disposition in plasma and tissues in mouse models of human colorectal cancer.
    Abuqayyas L; Balthasar JP
    J Pharmacokinet Pharmacodyn; 2012 Dec; 39(6):683-710. PubMed ID: 23184417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
    Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
    J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha.
    Robert B; Mach JP; Mani JC; Ychou M; Folli S; Artus JC; Pèlegrin A
    Cancer Res; 1996 Oct; 56(20):4758-65. PubMed ID: 8840995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigen.
    Sharkey RM; Kaltovich FA; Shih LB; Fand I; Govelitz G; Goldenberg DM
    Cancer Res; 1988 Jun; 48(11):3270-5. PubMed ID: 3365705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
    Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
    Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.